Published articles & abstracts Archive -

Download our app Order a test

Comparative study of Nanog, Oct3/4 and Sox2 gene expression following c-Met gene knockdown in Colon Cancer Stem Cells

Published: 6th November 2012

Dashboard: Comparative study of Nanog, Oct3/4 and Sox2 gene expression following c-Met gene knockdown in Colon Cancer Stem Cells

Authors: Chatziioannou M., Apostolou P., Toloudi M., Ioannou E., Hammon R., Hembry N.4, Kopic A., Komiotis D., Chlichlia K. ,Papasotiriou I.

Studying the 5382insC polymorphism, of BRCA1 gene, in breast cancer and breast cancer stem cell-like cells

Published: 19th October 2012

Dashboard: Studying the 5382insC polymorphism, of BRCA1 gene, in breast cancer and breast cancer stem cell-like cells

Authors: P. Apostolou, M. Toloudi , M. Chatziioannou , E. Ioannou, I Retsas, I. Papasotiriou

Determination of the cytotoxicity of potential medical substances by using three colorimetric assays for mammalian cells

Published: 19th October 2012

Dashboard: Determination of the cytotoxicity of potential medical substances by using three colorimetric assays for mammalian cells

Authors: M. Toloudi, P. Apostolou, M. Chatziioannou, E. Ioannou, I. Retsas, I. Papasotiriou

Circulating Tumor Cells (CTCs) as a biomarker of relapse and metastasis: A review of 21 patients with breast cancer

Published: 19th October 2012

Dashboard: Circulating Tumor Cells (CTCs) as a biomarker of relapse and metastasis A review of 21 patients with breast cancer

Authors: Chatziioannou M., Apostolou P., Toloudi M., Ioannou E., Retsas I. , R. Hammon, N. Hembry, U. Jacob, A. Kopic, Papasotiriou I.

Can Cancer stem cell – Like cells determine a therapeutic model in breast cancer patients when any other recommended therapy failed in this group? Considerations and single cases

Published: 11th October 2012

Dashboard: Can Cancer stem cell – Like cells determine a therapeutic model in breast cancer patients when any other recommended therapy failed in this group? Considerations and single cases

Authors: I. Papasotiriou, M. Chatziioannou, M. Toloudi, P. Apostolou, E. Ioannou, R. Hammon, N. Hembry, U. Jacob, A. Kopic

Colon Cancer Cells and Cancer Stem Cells: A growth curves comparison

Published: 11th October 2012

Dashboard: Colon Cancer Cells and Cancer Stem Cells: A growth curves comparison

Authors: E. Ioannou, M. Chatziioannou, M. Toloudi, P. Apostolou, I. Papasotiriou

Studying the interaction of four receptors of NOTCH signalling pathway in breast cancer

Published: 11th October 2012

Dashboard: Studying the interaction of four receptors of NOTCH signalling pathway in breast cancer

Authors: P. Apostolou, M. Toloudi, M. Chatziioannou, E. Ioannou, I. Papasotiriou

Studying the effect of stemness factors involved in molecular cascades of the development of colon cancer stem cells

Published: 11th October 2012

Dashboard: Studying the effect of stemness factors involved in molecular cascades of the development of colon cancer stem cells

Authors: M. Toloudi, P. Apostolou, M. Chatziioannou, E. Ioannou, I. Papasotiriou

Evaluation of clinical development of two patients with urinary bladder cancer before and after chemotherapy

Published: 11th October 2012

Dashboard: Evaluation of clinical development of two patients with urinary bladder cancer before and after chemotherapy

Authors: M. Chatziioannou, M. Toloudi, P. Apostolou, E. Ioannou, R. Hammon, N. Hembry, U. Jacob, A. Kopic, I. Papasotiriou

Correlation of Number of circulating tumor cells, chemotherapy and clinical development in breast cancer patients

Published: 11th October 2012

Dashboard: Correlation of Number of circulating tumor cells, chemotherapy and clinical development in breast cancer patients

Authors: M. Chatziioannou , M. Toloudi , P. Apostolou , E. Ioannou , R. Hammon, N. Hembry, U. Jacob, A. Kopic, I. Papasotiriou

Correlation of Number of circulating tumor cells and clinical development in patients with breast cancer of several stages

Published: 11th October 2012

Link: 404 Not Found

Authors: M. Chatziioannou 1, M. Toloudi 1 , P. Apostolou 1 , E. Ioannou 1 , R. Hammon 2, N. Hembry 4, U. Jacob3, A. Kopic 3, I. Papasotiriou

Cancer Stem Cell-Like cells: A Therapeutic model in breast cancer patients, where any other recommended therapy has failed

Published: 11th October 2012

Dashboard: Cancer Stem Cell-Like cells: A Therapeutic model in breast cancer patients, where any other recommended therapy has failed

Authors: I. Papasotiriou, M. Chatziioannou, M. Toloudi, E. Ioannou, R. Hammon, U. Jacob, N. Hembry, A. Kopic

Find out more about the science behind RGCC tests

Need help?

Can brain tumours also be tested with a blood sample?

No, due to the blood-brain barrier, tumour cells cannot enter the bloodstream. This means that we cannot obtain and isolate any tumour cells from the blood sample.

Is it possible to measure circulating tumour cells (CTC) in patients with lymphoma or leukaemia?

Yes, patients with lymphoma or leukaemia can use an RGCC test to measure the number of circulating tumour cells (CTC) they have.

Which test is the most comprehensive test?

The most comprehensive test is the “Onconomics Plus” test. This provides information on the sensitivity or resistance of the patient’s tumour cells to certain cancer drugs and shows options for targeted therapy or an alternative treatment method with organic substances. The test also contains information about the development of the tumour and its potential by identifying epigenetic tumour markers relevant for the therapy, which are crucial for the correct therapeutic approach.

How do online consultations work?

Online consultations will give you the opportunity to speak to any member of the RGCC Network at a time and place that is convenient to you. You will be able to choose from a shortlist of clinicians who best suit your needs. The online consultation will be available via the Cancer A-Z app soon… please keep checking the app for updates.

Will online consultations take place via Zoom, Skype, or another method?

Your chosen clinician will be in touch to make the arrangements and choose the most convenient method.

Didn't find an answer to your question? Contact us directly.

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.